Michael Wang, MD

Videos

Promising Advances in the Treatment of Patients With Mantle Cell Lymphoma

09/13/2023

At the 2023 Society of Hematologic Oncology Annual Meeting, Michael Wang, MD, reviews the latest research and treatment advances for patients with mantle cell lymphoma.

At the 2023 Society of...

09/13/2023

Oncology

Videos

Ibrutinib Plus Venetoclax Demonstrates Efficacy, Safety for TP53-Mutated Mantle Cell Lymphoma Treatment

07/09/2024

Michael Wang , MD;

Michael Wang, MD, presents data from the SYMPATICO trail on the encouraging efficacy and safety of ibrutinib plus venetoclax for patients with high-risk TP53-mutated mantle cell lymphoma.

Michael Wang, MD, presents data...

07/09/2024

Lymphoma, Leukemia & Myeloma Network

Commentary

Reviewing Promising Treatment Options for Patients With Mantle Cell Lymphoma

09/22/2023

Michael Wang , MD;

At the 2023 Society of Hematologic Oncology (SOHO) annual meeting in Houston, Texas, Michael Wang, MD, MD Anderson Cancer Center, Houston, Texas, speaks on the continually evolving landscape of research and treatment advances for patients...

At the 2023 Society of...

09/22/2023

First Report Managed Care